The effects of vilaprisan on the pharmacodynamics and pharmacokinetics of a combined oral contraceptive—A randomized controlled trial

AIMS: The primary objective was to explore whether the suppression of ovarian activity induced by a combined oral contraceptive (COC) is influenced by the simultaneous intake of the selective progesterone receptor modulator (SPRM) vilaprisan (VPR). METHODS: In this exploratory randomized, double‐bli...

Descripción completa

Detalles Bibliográficos
Autores principales: Schultze‐Mosgau, Marcus‐Hillert, Schütt, Barbara, Draeger, Corinna, Casjens, Manuela, Loewen, Stephanie, Zimmermann, Torsten, Rohde, Beate
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328435/
https://www.ncbi.nlm.nih.gov/pubmed/32592596
http://dx.doi.org/10.1111/bcp.14443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328435/
https://www.ncbi.nlm.nih.gov/pubmed/32592596
http://dx.doi.org/10.1111/bcp.14443

Ejemplares similares